search
Back to results

Improving Asthma Care Together (IMPACT): A Shared Management Pilot Study (IMPACT)

Primary Purpose

Asthma in Children

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Improving Asthma Care Together (IMPACT)
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Asthma in Children focused on measuring Self-management, Shared management, mHealth

Eligibility Criteria

7 Years - 11 Years (Child)All SexesDoes not accept healthy volunteers

CHILD Inclusion Criteria:

  • Clinician diagnosis of persistent asthma (prescription for daily asthma medication)
  • Speak English

PARENT Inclusion Criteria:

  • 18 years or older
  • Child's primary caregiver
  • Able to understand and read English
  • Reside with the child 50% or more
  • Legal guardian who can consent for child to participate
  • Have access to a smart phone and reliable home internet access

CHILD Exclusion Criteria:

  • Parent report of developmental delay (language < 5 year level)
  • Co-morbid cancer, diabetes, ADHD
  • Current asthma exacerbation at the time of recruitment

Sites / Locations

  • University of Washington School of Nursing

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

IMPACT Intervention

Usual care control

Arm Description

IMPACT health application and wearable device

Usual care control.

Outcomes

Primary Outcome Measures

Asthma responsibility questionnaire change from baseline to 8 weeks
10- items, 5-point scale to report asthma management task responsibility, higher scores indicate higher asthma management responsibility for child.
Asthma responsibility questionnaire change from 8 to 16 weeks
10- items, 5-point scale to report asthma management task responsibility, higher scores indicate higher asthma management responsibility for child.
Asthma management self-efficacy change from baseline to 8 weeks
13-items (parent) and 12-items (child), 5-point scale assesses asthma self-efficacy, higher scores indicate higher selfefficacy.
Asthma management self-efficacy change from 8 weeks to 16 weeks
13-items (parent) and 12-items (child), 5-point scale assesses asthma self-efficacy, higher scores indicate higher selfefficacy.

Secondary Outcome Measures

Spirometry - FEV1 change from baseline to 8 weeks
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Specifically, the FEV1 measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Spirometry - FEV1 change from 8 weeks to 16 weeks
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Specifically, the FEV1 measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Spirometry - FEV1
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Intervention group will measure weekly via home spirometry device and IMPACT application. Specifically, the FEV1 measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Spirometry - FEV1/FVC change from baseline to 8 weeks
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Specifically, the FEV1/FVC measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Spirometry - FEV1/FVC change from 8 weeks to 16 weeks
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Specifically, the FEV1/FVC measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Spirometry - FEV1/FVC
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Intervention group will measure weekly via home spirometry device and IMPACT application. Specifically, the FEV1/FVC measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Childhood Asthma Control Test change from baseline to 8 weeks
7 total items--3 parent (5-point scale) and 4 child (3-point scale)-- assess asthma control, higher scores indicate better control
Childhood Asthma Control Test
7 total items--3 parent (5-point scale) and 4 child (3-point scale)-- assess asthma control, higher scores indicate better control
Childhood Asthma Control Test change from 8 weeks to 16 weeks
7 total items--3 parent (5-point scale) and 4 child (3-point scale)-- assess asthma control, higher scores indicate better control
Childhood Asthma Quality of Life change from baseline to 8 weeks
Self-report child-reported asthma quality of life, with higher scores indicating better quality of life. PROMIS Asthma Impact Scale - 8 items, 5-point scale
Childhood Asthma Quality of Life change from 8 weeks to 16 weeks
Self-report child-reported asthma quality of life, with higher scores indicating better quality of life. PROMIS Asthma Impact Scale - 8 items, 5-point scale
Parent Asthma Quality of Life change from baseline to 8 weeks
Self-report parent-reported asthma quality of life, with higher scores indicating better quality of life. PROMIS Asthma Impact Scale - 8 items, 5-point scale
Parent Asthma Quality of Life change from 8 weeks to 16 weeks
Self-report parent-reported asthma quality of life, with higher scores indicating better quality of life. PROMIS Asthma Impact Scale - 8 items, 5-point scale
Acceptability of intervention measure
4 items using 5-point scale; higher scores indicate higher acceptability.
Medication adherence change from baseline to 8 weeks
Medication Adherence Report Scale for Asthma, 10-items, 5-point scale assessing reported asthma controller medication adherence. Higher scores indicate better adherence.
Medication adherence change from 8 weeks to 16 weeks
Medication Adherence Report Scale for Asthma, 10-items, 5-point scale assessing reported asthma controller medication adherence. Higher scores indicate better adherence.
Feasibility of intervention (intervention group only)
Feasibility of intervention 4-items, 5-point scale, with higher scores indicating higher feasibility.
System usability scale (intervention group only)
System usability scale - 10 items, 5-point scale to determine perceived usability of a system. Higher scores indicate higher usability.
Semi-structured interview (intervention group only)
12-question semi-structured interview to determine parent and child acceptability of intervention and elicit feedback and suggested revisions.

Full Information

First Posted
September 29, 2020
Last Updated
May 12, 2023
Sponsor
University of Washington
Collaborators
National Institute of Nursing Research (NINR), National Center for Advancing Translational Sciences (NCATS)
search

1. Study Identification

Unique Protocol Identification Number
NCT04908384
Brief Title
Improving Asthma Care Together (IMPACT): A Shared Management Pilot Study
Acronym
IMPACT
Official Title
Improving Asthma Care Together (IMPACT): A Shared Management Pilot Study for Children With Asthma and Their Parents
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 7, 2021 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
September 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
National Institute of Nursing Research (NINR), National Center for Advancing Translational Sciences (NCATS)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study aims to iteratively develop, refine and test the Improving Asthma Care Together (IMPACT) Intervention for school-age children (7-11 years) with persistent asthma and their parents.
Detailed Description
Asthma is one of the most common chronic conditions of childhood, affecting over six million US children. Asthma treatment relies on self-management including symptom monitoring and response, trigger avoidance, and timely and appropriate medication use. Unfortunately, fewer than 50% of children with asthma are adherent to asthma treatment regimens, leading to increased disease morbidity and mortality and potentially irreversible airway damage. Children with asthma are missing a voice in their own care. The school-age years (7-11) represent a natural transition in asthma management, as children must assume some responsibility for asthma-related care while they spend increasing time away from parents at school and other extracurricular activities. Yet, existing interventions focus on parents alone and use prescriptive approaches, telling the parent what to "do" to the child to manage their asthma. As a result, current strategies are failing to provide children with asthma and their families the tools they need to manage asthma successfully within the realities of their daily lives. Using a Human-Centered Design (HCD) framework, the investigators co-designed a tailored asthma shared management mobile health application that pairs the parent and child together as a team and facilitates the intentional transition of some asthma management to the child. The hypothesis is that by involving children in their own care, participants will improve asthma management in the present, but also establish lifelong successful self-management skills. The objective of the proposed study is to pilot test the Improving Asthma Care Together (IMPACT) mobile health application with parent-child dyads. Based on the preliminary data, the central hypothesis is that IMPACT will be effective for delivering a shared asthma management intervention for children and their parents.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma in Children
Keywords
Self-management, Shared management, mHealth

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
IMPACT Intervention
Arm Type
Experimental
Arm Description
IMPACT health application and wearable device
Arm Title
Usual care control
Arm Type
No Intervention
Arm Description
Usual care control.
Intervention Type
Behavioral
Intervention Name(s)
Improving Asthma Care Together (IMPACT)
Intervention Description
IMPACT is a novel health application and wearable device
Primary Outcome Measure Information:
Title
Asthma responsibility questionnaire change from baseline to 8 weeks
Description
10- items, 5-point scale to report asthma management task responsibility, higher scores indicate higher asthma management responsibility for child.
Time Frame
8 weeks
Title
Asthma responsibility questionnaire change from 8 to 16 weeks
Description
10- items, 5-point scale to report asthma management task responsibility, higher scores indicate higher asthma management responsibility for child.
Time Frame
16 weeks
Title
Asthma management self-efficacy change from baseline to 8 weeks
Description
13-items (parent) and 12-items (child), 5-point scale assesses asthma self-efficacy, higher scores indicate higher selfefficacy.
Time Frame
8 weeks
Title
Asthma management self-efficacy change from 8 weeks to 16 weeks
Description
13-items (parent) and 12-items (child), 5-point scale assesses asthma self-efficacy, higher scores indicate higher selfefficacy.
Time Frame
16 weeks
Secondary Outcome Measure Information:
Title
Spirometry - FEV1 change from baseline to 8 weeks
Description
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Specifically, the FEV1 measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Time Frame
8 weeks
Title
Spirometry - FEV1 change from 8 weeks to 16 weeks
Description
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Specifically, the FEV1 measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Time Frame
16 weeks
Title
Spirometry - FEV1
Description
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Intervention group will measure weekly via home spirometry device and IMPACT application. Specifically, the FEV1 measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Time Frame
Weekly through intervention (weeks 0 through 8)
Title
Spirometry - FEV1/FVC change from baseline to 8 weeks
Description
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Specifically, the FEV1/FVC measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Time Frame
8 weeks
Title
Spirometry - FEV1/FVC change from 8 weeks to 16 weeks
Description
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Specifically, the FEV1/FVC measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Time Frame
16 weeks
Title
Spirometry - FEV1/FVC
Description
Spirometry - objective measure of expiratory lung function will be used to evaluate asthma control. Intervention group will measure weekly via home spirometry device and IMPACT application. Specifically, the FEV1/FVC measure will be used and interpreted according to the national spirometry guideline cutpoints (NAEPP EPR4 report)
Time Frame
Weekly through intervention (weeks 0 through 8)
Title
Childhood Asthma Control Test change from baseline to 8 weeks
Description
7 total items--3 parent (5-point scale) and 4 child (3-point scale)-- assess asthma control, higher scores indicate better control
Time Frame
8 weeks
Title
Childhood Asthma Control Test
Description
7 total items--3 parent (5-point scale) and 4 child (3-point scale)-- assess asthma control, higher scores indicate better control
Time Frame
Weekly through intervention (week 0 through 8)
Title
Childhood Asthma Control Test change from 8 weeks to 16 weeks
Description
7 total items--3 parent (5-point scale) and 4 child (3-point scale)-- assess asthma control, higher scores indicate better control
Time Frame
16 weeks
Title
Childhood Asthma Quality of Life change from baseline to 8 weeks
Description
Self-report child-reported asthma quality of life, with higher scores indicating better quality of life. PROMIS Asthma Impact Scale - 8 items, 5-point scale
Time Frame
8 weeks
Title
Childhood Asthma Quality of Life change from 8 weeks to 16 weeks
Description
Self-report child-reported asthma quality of life, with higher scores indicating better quality of life. PROMIS Asthma Impact Scale - 8 items, 5-point scale
Time Frame
16 weeks
Title
Parent Asthma Quality of Life change from baseline to 8 weeks
Description
Self-report parent-reported asthma quality of life, with higher scores indicating better quality of life. PROMIS Asthma Impact Scale - 8 items, 5-point scale
Time Frame
8 weeks
Title
Parent Asthma Quality of Life change from 8 weeks to 16 weeks
Description
Self-report parent-reported asthma quality of life, with higher scores indicating better quality of life. PROMIS Asthma Impact Scale - 8 items, 5-point scale
Time Frame
16 weeks
Title
Acceptability of intervention measure
Description
4 items using 5-point scale; higher scores indicate higher acceptability.
Time Frame
8 weeks
Title
Medication adherence change from baseline to 8 weeks
Description
Medication Adherence Report Scale for Asthma, 10-items, 5-point scale assessing reported asthma controller medication adherence. Higher scores indicate better adherence.
Time Frame
8 weeks
Title
Medication adherence change from 8 weeks to 16 weeks
Description
Medication Adherence Report Scale for Asthma, 10-items, 5-point scale assessing reported asthma controller medication adherence. Higher scores indicate better adherence.
Time Frame
16 weeks
Title
Feasibility of intervention (intervention group only)
Description
Feasibility of intervention 4-items, 5-point scale, with higher scores indicating higher feasibility.
Time Frame
8 weeks
Title
System usability scale (intervention group only)
Description
System usability scale - 10 items, 5-point scale to determine perceived usability of a system. Higher scores indicate higher usability.
Time Frame
8 weeks
Title
Semi-structured interview (intervention group only)
Description
12-question semi-structured interview to determine parent and child acceptability of intervention and elicit feedback and suggested revisions.
Time Frame
8 weeks
Other Pre-specified Outcome Measures:
Title
Family functioning change from baseline to 8 weeks
Description
McMaster Family Assessment Device, 60-item parent-report instrument, 4-point scale to evaluate family functioning. Higher scores indicate worsened levels of functioning.
Time Frame
8 weeks
Title
Family functioning change from 8 weeks to 16 weeks
Description
McMaster Family Assessment Device, 60-item parent-report instrument, 4-point scale to evaluate family functioning. Higher scores indicate worsened levels of functioning.
Time Frame
16 weeks
Title
Illness perception change from baseline to 8 weeks
Description
Brief Illness Perception Questionnaire, 8-items, 10-point scale to assess individual beliefs about a health condition. Higher scores indicate more burdensome perception.
Time Frame
8 weeks
Title
Illness perception change from 8 weeks to 16 weeks
Description
Brief Illness Perception Questionnaire, 8-items, 10-point scale to assess individual beliefs about a health condition. Higher scores indicate more burdensome perception.
Time Frame
16 weeks
Title
Medication Beliefs change from baseline to 8 weeks
Description
Beliefs about Medicines Questionnaire, 10 items, 5-point scale to assess perceived medication necessity and concerns. Medication necessity scores range from 5 to 25. Medication concerns scores range from 5 to 25. Necessity-concern differential calculated to determine whether concerns outweigh perceived necessity. Positive (higher) scores indicate perceived necessity outweighing concerns whereas negative scores indicate concerns outweigh the necessity.
Time Frame
8 weeks
Title
Medication Beliefs change from 8 weeks to 16 weeks
Description
Beliefs about Medicines Questionnaire, 10 items, 5-point scale to assess perceived medication necessity and concerns. Medication necessity scores range from 5 to 25. Medication concerns scores range from 5 to 25. Necessity-concern differential calculated to determine whether concerns outweigh perceived necessity. Positive (higher) scores indicate perceived necessity outweighing concerns whereas negative scores indicate concerns outweigh the necessity.
Time Frame
16 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
11 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
CHILD Inclusion Criteria: Clinician diagnosis of persistent asthma (prescription for daily asthma medication) Speak English PARENT Inclusion Criteria: 18 years or older Child's primary caregiver Able to understand and read English Reside with the child 50% or more Legal guardian who can consent for child to participate Have access to a smart phone and reliable home internet access Reported Asthma Responsibility Questionnaire score < or = 2.5 at screening CHILD Exclusion Criteria: Parent report of developmental delay (language < 5 year level) Co-morbid cancer, diabetes, ADHD Current asthma exacerbation at the time of recruitment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer T Sonney, PhD
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Washington School of Nursing
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35144958
Citation
Sonney J, Ward T, Thompson HJ, Kientz JA, Segrin C. Improving Asthma Care Together (IMPACT) mobile health intervention for school-age children with asthma and their parents: a pilot randomised controlled trial study protocol. BMJ Open. 2022 Feb 10;12(2):e059791. doi: 10.1136/bmjopen-2021-059791.
Results Reference
derived

Learn more about this trial

Improving Asthma Care Together (IMPACT): A Shared Management Pilot Study

We'll reach out to this number within 24 hrs